1. Home
  2. BMI vs GKOS Comparison

BMI vs GKOS Comparison

Compare BMI & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMI
  • GKOS
  • Stock Information
  • Founded
  • BMI 1905
  • GKOS 1998
  • Country
  • BMI United States
  • GKOS United States
  • Employees
  • BMI N/A
  • GKOS N/A
  • Industry
  • BMI Industrial Machinery/Components
  • GKOS Medical/Dental Instruments
  • Sector
  • BMI Industrials
  • GKOS Health Care
  • Exchange
  • BMI Nasdaq
  • GKOS Nasdaq
  • Market Cap
  • BMI 5.4B
  • GKOS 5.1B
  • IPO Year
  • BMI N/A
  • GKOS 2015
  • Fundamental
  • Price
  • BMI $216.15
  • GKOS $96.63
  • Analyst Decision
  • BMI Buy
  • GKOS Strong Buy
  • Analyst Count
  • BMI 6
  • GKOS 13
  • Target Price
  • BMI $227.67
  • GKOS $155.00
  • AVG Volume (30 Days)
  • BMI 317.3K
  • GKOS 1.0M
  • Earning Date
  • BMI 04-17-2025
  • GKOS 04-30-2025
  • Dividend Yield
  • BMI 0.63%
  • GKOS N/A
  • EPS Growth
  • BMI 30.84
  • GKOS N/A
  • EPS
  • BMI 4.54
  • GKOS N/A
  • Revenue
  • BMI $852,489,000.00
  • GKOS $383,481,000.00
  • Revenue This Year
  • BMI $13.38
  • GKOS $27.84
  • Revenue Next Year
  • BMI $8.20
  • GKOS $27.99
  • P/E Ratio
  • BMI $47.47
  • GKOS N/A
  • Revenue Growth
  • BMI 15.08
  • GKOS 21.85
  • 52 Week Low
  • BMI $162.17
  • GKOS $77.91
  • 52 Week High
  • BMI $239.11
  • GKOS $163.71
  • Technical
  • Relative Strength Index (RSI)
  • BMI 66.60
  • GKOS 50.06
  • Support Level
  • BMI $167.69
  • GKOS $87.17
  • Resistance Level
  • BMI $218.93
  • GKOS $98.86
  • Average True Range (ATR)
  • BMI 9.70
  • GKOS 5.59
  • MACD
  • BMI 4.66
  • GKOS 1.78
  • Stochastic Oscillator
  • BMI 95.10
  • GKOS 88.89

About BMI Badger Meter Inc.

Badger Meter Inc is an innovator, manufacturer, and marketer of products incorporating flow measurement, quality, control, and other system solutions serving markets. The company's products measure water, oil, chemicals, and other fluids, and provide and communicate timely measurement data. Its product lines include two categories: sales of water meters, radios, software, and related technologies, and water quality monitoring solutions to water utilities (utility water) and sales of meters and other sensing instruments, valves, software, and other solutions for industrial applications in water, wastewater, and other industries (flow instrumentation). It derives a majority of its revenues from the United States.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: